πŸ‡ΊπŸ‡Έ FDA
Patent

US 6252093

Total synthesis of antitumor acylfulvenes

expired A61PA61P35/00

Quick answer

US patent 6252093 (Total synthesis of antitumor acylfulvenes) held by The Regents of the University of California expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00